ERVK-32, endogenous retrovirus group K member 32, envelope, 110006328
N. diseases: 158; N. variants: 0
Source: ALL
Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year |
---|---|---|---|---|---|---|---|
|
0.050 | GeneticVariation | disease | BEFREE | Phylogenetic analysis of the env gene showed that all the Cuban sequences clustered in group A of HIV-2. | 24925342 | 2014 |
|
0.050 | Biomarker | disease | BEFREE | In the present case study, we attempted to observe amino acid substitutions in Gag and Env proteins and related parameters possibly associated with an increase in HIV-2 load. | 18622680 | 2008 |
|
0.050 | Biomarker | disease | BEFREE | The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. | 8995671 | 1997 |
|
0.050 | Biomarker | disease | BEFREE | The V3 and V4 domains of human immunodeficiency virus type 2 (HIV-2) env genes from 14 rhesus macaques experimentally infected by HIV-2 SBL6669/H5 were sequenced. | 8151803 | 1994 |
|
0.050 | Biomarker | disease | BEFREE | To investigate the glycoprotein determinants of viral cytopathology, we constructed chimeric env genes between a noncytopathic strain of human immunodeficiency virus type 2 (HIV-2), designated HIV-2/ST, and a highly fusogenic and cytopathic variant derived from this virus. | 1583738 | 1992 |